Ark Therapeutics Group plc
About Ark Therapeutics Group
Ark Therapeutics Group plc is a specialist healthcare group with operations in the UK and Finland. Ark focuses on high value areas of unmet medical need within vascular disease, wound care and cancer. These are large and growing markets, where opportunities exist for effective new products to generate significant revenues. With five marketed devices, Kerraboot®, Kerraped®, Flaminal®, Kerramax® and Neuropad®, and three further lead pharmaceutical products in late stage clinical development: Cerepro®, Vitor™, and Trinam®, the Group is transitioning from an R&D company to a commercial, revenue generating business.
Facts about Ark Therapeutics Group
Facts about Ark Therapeutics Group
- Focus : Manufacturer
- Industry : Pharma
